A Nomogram for Predicting Suicide Risk and Prognostic Factors in Bladder Cancer Patients Following Diagnosis: More Information Needed
Click on the article title to read more.
Related Articles
Super regulator supports voluntary register for NHS managers | Nursing Times
Read about the evidence that the chief executive of the Professional Standards Authority, Dr Alan Clamp, gave to the Thirlwall Inquiry.
Over a third of practice nurses spend one hour or less on training a week
More than a third (36%) of general practice nursing staff say they spend one hour or less per week on training and development opportunities
‘It’s time to talk about our mental health as internationally trained nurses’ | Nursing Times
Sun Sander-Jackson reflects on how past experiences of racism, microaggression and sexism have affected her mental health and getting support.
Hope as a mediator enhancing family resilience in patients with gynaecological cancer
Commentary on: Xu X, Li M. Illness perception and family resilience in gynaecologic cancer patients: A study on the mediating role of hope. J Adv…
The Relationship Between Discomfort Intolerance And the Fear Of Self‐Injection And Testing In Patients With Diabetes Using Insulin: A Cross‐Sectional Study
Background Diabetes is a global problem. Diabetes nurses, in particular, take great responsibility in reducing and controlling the fears of individuals using insulin and increasing…
Embracing Change in the Face of Aging and Breast Cancer
I’ve learned to embrace the changing nature of my body as I age, accepting the challenges and finding gratitude in each day.
FDA Accepts New Drug Application For Taletrectinib in ROS1+ NSCLC
The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell lung cancer.
Adherence to Evidence‐Based Guidelines and Implications When Designing Electronic Documentation for Urinary Catheters
Aim The aim of this study was to investigate the point prevalence and the rate of adherence to evidence-based guidelines for patients who had indwelling…
CAR T-Cell Therapy Yescarta Continues to Demonstrate Durable Responses in Follicular Lymphoma
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma.
UK cut funds to ‘red list’ countries while ‘heavily recruiting’ their nurses
The government has been accused of cutting crucial health spending aid to countries with severe nursing shortages, while ‘heavily’ recruiting